Boundless Bio, Inc. (BOLD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

WORTHINGTON, Ohio, October 14, 2025--(BUSINESS WIRE)--I Am Boundless, Inc., a nonprofit leader in integrated care for individuals with intellectual and developmental disabilities (I/DD) and behavioral ...

Boundless announced the following updates to its portfolio of novel ecDTx programs for a range of aggressive and difficult-to-treat cancer indications: Initial clinical data readout for BBI-355 on ...

Targeted therapies and immunotherapies offer new treatment options for more types of cancer, but these drugs are less helpful when tumors produce multiple copies of a gene. This gene amplification ...

Seattle-based startup Boundless laid off four employees and asked 27 workers to relocate to Las Vegas as part of what CEO Xiao Wang described as a restructuring. The online immigration service in ...

Boundless Bio finds its roots in a simple question—how do cancer cells evolve so quickly? In seeking an answer, Boundless founder Paul Mischel, M.D., revisited questions that had been considered put ...

Just when it seemed like the biotech IPOs were being lulled back to sleep, Boundless Bio says it plans to hit Wall Street. The Arch-, Bayer- and RA-backed company filed an S-1 Wednesday afternoon, ...

Boundless Bio has announced a strategic portfolio prioritization aimed at optimizing its oncology programs, particularly focusing on the combination therapy of BBI-355 and BBI-825, alongside a new ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Apr 22, 2021 at ...

Our education system is broken, from lower-level public schools all the way up to higher learning. EdTech startups are coming at the numerous problems from every angle. Boundless, a startup out of ...